Correlates of Physical Functioning and Performance Across the Spectrum of Kidney Function

E Segura-Ortí1, P L Gordon2, J W Doyle3

  • 11 Universidad CEU Cardenal Herrera, Valencia, Spain.

Clinical Nursing Research
|January 25, 2017
PubMed

Insights

Early-stage chronic kidney disease (CKD) patients exhibit low physical activity and muscle size, similar to those on hemodialysis. Interventions targeting muscle mass and energy expenditure may improve physical function in CKD.

Area of Science:

  • Nephrology
  • Exercise Physiology
  • Geriatrics

Background:

  • Patients on hemodialysis often experience poor physical functioning, low physical activity, and muscle atrophy.
  • These physical impairments are significant concerns impacting quality of life and clinical outcomes.

Purpose of the Study:

  • To investigate the presence and severity of physical activity limitations and muscle atrophy in earlier stages of chronic kidney disease (CKD).
  • To compare physical functioning, activity levels, and muscle characteristics across different stages of CKD, including no CKD, stages 3-4 CKD, and hemodialysis.

Main Methods:

  • Adult participants were categorized into three groups: no CKD, stages 3-4 CKD, and hemodialysis.
  • Key outcomes assessed included physical activity levels, muscle size (area), thigh muscle strength, physical performance tests, and self-reported physical function.

Main Results:

  • Patients with stages 3-4 CKD demonstrated intermediate muscle area compared to healthy controls and hemodialysis patients.
  • Despite intermediate muscle size, CKD patients exhibited low physical activity levels comparable to the hemodialysis group.
  • Both physical activity and muscle size were significantly correlated with all measured physical function outcomes.

Conclusions:

  • Physical activity and muscle size, rather than kidney function itself, are key determinants of physical function in CKD.
  • Interventions focused on enhancing muscle mass and increasing energy expenditure show promise for improving the physical function of individuals with chronic kidney disease.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
534
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
548
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
854
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
561